GO
Loading...

Mark Koba

Mark Koba
Senior Editor, CNBC

Mark Koba is a senior editor at CNBC.com. Topics for his feature story writing include the business of politics, health care, employment and the economy.

Before working at CNBC.com, he spent 11 years at Bloomberg LP, where among various duties, he was program producer for the award-winning "Bloomberg Small Business" television show.

Koba's background includes a decade of news writing and show producing at CNN, E! Entertainment Television, ABC's "World News Now," "Good Morning America" and CBS' "This Morning."

Follow Mark Koba on Twitter @MarkKobaCNBC.

More

  • We've mentioned today's report on global warming in an earlier post--so let's get right to one of the major questions: is corporate America taking global warming as a serious issue or not? Some are it seems as reported earlier this month when 10 companies and their CEOs joined activist groups in calling for caps on carbon emissions.

  • Global Warming Still A Hot Topic
    By: Mark Koba
    Friday, 2 Feb 2007 | 9:15 AM ET

    Are humans responsible for global warming--or not? A new report says--yes. Scientists from 113 countries issued the report Friday--saying they have little doubt global warming is caused by man, and predicting that hotter temperatures and rises in sea level will “continue for centuries” no matter how much humans control their pollution.

  • Tamiflu "Flies High" In Bird Flu Battle
    By: Mark Koba
    Thursday, 1 Feb 2007 | 10:36 AM ET

    Some 270 people have contracted the H5N1 virus or avian flu, according to the World Health Organization, and 164 of them have died. It's the high death rate--greater than 50%--that has alarmed so many health officials. One drug that is on the market for patients is Tamiflu--made by Gildead Sciences. Sales of the drug have made a big turnaround over the last few years...